{"id":"W3161919645","doi":"10.1038/s41375-021-01261-x","title":"Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Novartis Pharmaceuticals Corporation","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Anemia; Adverse effect; Dosing; Internal medicine; Polycythemia vera; Gastroenterology; Hemoglobin; Phases of clinical research; Surgery; Clinical trial; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001126235,0.0001550475,0.0003683029,0.00003282074,0.00007736361,0.00001602483,0.00003278049,0.00003964201,0.000006136719],"category_scores_gemma":[0.00003739883,0.00007247412,0.0000368535,0.000143479,0.00008839529,0.00003025153,0.00001250455,0.00005314359,6.044079e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001168982,"about_ca_system_score_gemma":0.0001543105,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002036085,"about_ca_topic_score_gemma":0.0001726814,"domain_scores_codex":[0.9990974,0.00006433661,0.000286627,0.0002345561,0.0001750814,0.0001420021],"domain_scores_gemma":[0.9989435,0.0005381292,0.0001120391,0.000248357,0.0001124701,0.00004547455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01163697,0.02871872,0.8505425,0.0003286312,0.0006452035,0.00006732638,0.02389988,0.00009157462,0.0009119812,0.001085702,0.00006317048,0.08200836],"study_design_scores_gemma":[0.06397943,0.01164794,0.9157104,0.0001803049,0.0005366632,0.00001245073,0.003182931,0.00009149886,0.004288955,0.00001277924,0.00027205,0.0000845164],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966174,0.0003627973,0.00001604626,0.0002206021,0.000009939057,0.00245636,0.0001699183,0.000003742376,0.0001431419],"genre_scores_gemma":[0.9989408,0.0002280497,0.0003367017,0.00006281876,0.00002220331,0.0002874383,0.00009060017,0.00001129504,0.00002014071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08192384,"threshold_uncertainty_score":0.2955409,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03425455265126314,"score_gpt":0.3173339949928264,"score_spread":0.2830794423415633,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}